Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
The Liver Meeting 2023: American Association for the Study of Liver Diseases (AASLD)
November 10 - 14, 2023; Boston, Massachusetts/Virtual
November 10 - 14, 2023Boston, Massachusetts/Virtual
AASLD 2023Low-Dose Aspirin Reduces Liver Fat, Inflammation MarkersA single daily low dose of aspirin significantly reduced hepatic fat fraction and liver transaminase levels in a randomized trial in patients with metabolic-associated steatotic liver disease.
Medscape Medical News, November 16, 2023
AASLD 2023Weight-Loss Drugs Improve Liver Measures TooFor patients who experienced rapid and significant weight reduction while taking an SGLT-2 inhibitor or a GLP-1 agonist, ALT values normalized, suggesting a beneficial effect on liver health.
Medscape Medical News, November 13, 2023
AASLD 2023MASLD, MASH Projected to Grow by 23% in the US Through 2050A mathematical model forecasts a steady increase in liver disease burden, including a near doubling of liver cancers and a more than twofold increase in liver transplants.
